Lacosamide
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141563This classification denotes an anticonvulsant agent with the molecular formula C13H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 563KS2PQY5, chemically known as 2-(acetylamino)-3-methoxy-n-(phenylmethyl)propanamide, (2r)- but generally known as lacosamide, which bears US NIH Compound Identifier 219078. European Medicines Agency schedules Lacosamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25407. The term LACOSAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 3, 2004, List 52). World Health Organization schedules lacosamide in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule lacosamide under HS 29242995 and SITC 51479. As of Q4 2014, LACOSAMIDE remains the US FDA Preferred Term for this commodity. Lacosamide bears US NLM identifiers UMLS ID C1311230 and NCI Concept Code C83859. SMILES: O(CC(NC(=O)C)C(=O)NCC1CCCCC1)C.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.